Celularity Inc. (CELU) vs Instil Bio, Inc. (TIL)
A side-by-side comparison of Celularity Inc. and Instil Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TIL
Instil Bio, Inc.
$6.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CELU vs TIL
growth of $100 · dividends reinvested · last 6yCELU -98.3% (-49.3%/yr)TIL -98.7% (-51.4%/yr)CELU compounded faster over this window
CELU TIL
CELU vs TIL: by the numbers
- •TIL is the larger company ($47M vs $46M market cap).
- •Both run net losses; TIL's is the smaller (0.00% vs -375.77% net margin).
Metrics side by side
Valuation
| Metric | CELU | TIL |
|---|---|---|
| P/S ratio | 2.41 | N/A |
| P/B ratio | N/A | 0.43 |
Profitability
| Metric | CELU | TIL |
|---|---|---|
| Gross margin | 79.62% | 0.00% |
| Operating margin | -230.92% | 0.00% |
| Net margin | -375.77% | 0.00% |
| ROE | N/A | -28.20% |
| ROIC | -192.99% | -18.61% |
Growth (annualized)
| Metric | CELU | TIL |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | N/A |
| Total return CAGR (5Y) | -52.57% | -54.60% |
Frequently asked
- How have CELU and TIL total returns compared?
- Over the past 5 years, CELU delivered -52.57% and TIL delivered -54.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.